Europe Pharmacy Automation Market - Forecasts from 2025 to 2030
Description
The Europe Pharmacy Automation Market is expected to grow from US$2,537.216 million in 2025 to US$3,546.100 million in 2030, at a CAGR of 6.92%.
Europe being a capital-intensive country the demand for automation has increased in several sectors including the pharmaceutical market. With growing research and development activities in the healthcare and pharma sector along with the growing technologies like artificial intelligence (AI) and machine learning (ML) automation algorithms, the market for European pharmacy automation is anticipated to grow on a substantial scale. Also, with the government-aided funding schemes for the pharma industry, the future of the segment is highly projected to incorporate the newest technological reforms like pharmacy automation.
Rapid innovations in the automation industry like robotic dispensers and automated tablet packaging machines are further expected to fuel the growth of the European pharmacy automation industry during the forecast period. Also, the increasing penetration of health-tech start-ups in Europe and evolving drug development discoveries are prominent contributors to determining the future growth of the pharmacy automation market. Additionally, with the increasing demographic aging population, the need for delivering pharma services and products for the elderly is expected to transform into a flexible, faster, and efficient means making the accessibility to medicines and other crucial supplies for the sound health of the old population, thereby serving as a vital factor in propelling the growth of the European pharmacy automation market. However, the regulatory laws and guidelines laid down by the European government bodies on technologies like artificial intelligence are expected to restrain the overall growth of the European pharmacy market owing to the unfavorable regulations for the robotics and automation players.
Europe Pharmacy Automation Market Growth Factors:
Increasing Research and Development, Innovations, and Investments in Healthcare
The Europe pharmacy automation market is expected to show significant growth in the future owing to the high expenditure spent by companies and governments on research and development along with the innovations and other investments in the healthcare segment. Moreover, new innovations and projects by pharma companies are expected for the future demand for automation in the pharma sector.
Growing Healthtech, Drug Development, and Aging Population
The growing emergence of health-tech start-ups in the European region and increasing drug development are vital factors for enabling the future growth of the European pharmacy automation market. With artificial intelligence (AI) marking its presence globally including in healthcare, the rise of health-tech start-ups is expected to have a rapid increase. Growing adoption of telemedicine and other advanced functionalities and operational innovations by leveraging AI, the European Pharmacy automation market is expected to surge in a substantial manner. Major drug developing companies in Europe are extensively deploying AI in their cycle of drug development.
Further, the growing aging population in Europe is another driving factor for the growth of the Europe pharmacy automation market in the future. With the increase in the elderly population, the healthcare segment in Europe is expected to transform to provide efficient healthcare to elderly patients along with flexible pharma deliveries.
Europe Pharmacy Automation Market Restraint:
Non-Favorable European Laws towards the Automation Industry
The European standards and laws for the automation industry and technologies like Artificial Intelligence (AI) are not in the best interest of the robotics and automation players who are willing to drive the market and develop solutions for industries like pharmacy automation. Also, the regulation considers some social scoring and biometric surveillance as unacceptable risks to aspects like privacy, non-discrimination, and other human rights.
Europe Pharmacy Automation Market Segmentation:
By Component
Hardware
Software
Services
By Technology
Robotics-Based Automation
Carousel-Based Systems
RFID and Barcode Integration
AI-Driven Workflow Systems
By Application
Automated Dispensing System
Automated Packaging and Labeling System
Automatic Storage and Retrieval System
IV Pharmacy
Others
By End-User
Hospital Pharmacy
Retail Pharmacy
By Country
United Kingdom
Germany
France
Spain
Others
Companies Profiled
Omnicell
McKesson Corporation
BD Rowa
Capsa Healthcare
ARxIUM
Swisslog Healthcare
Parata Systems
Europe being a capital-intensive country the demand for automation has increased in several sectors including the pharmaceutical market. With growing research and development activities in the healthcare and pharma sector along with the growing technologies like artificial intelligence (AI) and machine learning (ML) automation algorithms, the market for European pharmacy automation is anticipated to grow on a substantial scale. Also, with the government-aided funding schemes for the pharma industry, the future of the segment is highly projected to incorporate the newest technological reforms like pharmacy automation.
Rapid innovations in the automation industry like robotic dispensers and automated tablet packaging machines are further expected to fuel the growth of the European pharmacy automation industry during the forecast period. Also, the increasing penetration of health-tech start-ups in Europe and evolving drug development discoveries are prominent contributors to determining the future growth of the pharmacy automation market. Additionally, with the increasing demographic aging population, the need for delivering pharma services and products for the elderly is expected to transform into a flexible, faster, and efficient means making the accessibility to medicines and other crucial supplies for the sound health of the old population, thereby serving as a vital factor in propelling the growth of the European pharmacy automation market. However, the regulatory laws and guidelines laid down by the European government bodies on technologies like artificial intelligence are expected to restrain the overall growth of the European pharmacy market owing to the unfavorable regulations for the robotics and automation players.
Europe Pharmacy Automation Market Growth Factors:
Increasing Research and Development, Innovations, and Investments in Healthcare
The Europe pharmacy automation market is expected to show significant growth in the future owing to the high expenditure spent by companies and governments on research and development along with the innovations and other investments in the healthcare segment. Moreover, new innovations and projects by pharma companies are expected for the future demand for automation in the pharma sector.
Growing Healthtech, Drug Development, and Aging Population
The growing emergence of health-tech start-ups in the European region and increasing drug development are vital factors for enabling the future growth of the European pharmacy automation market. With artificial intelligence (AI) marking its presence globally including in healthcare, the rise of health-tech start-ups is expected to have a rapid increase. Growing adoption of telemedicine and other advanced functionalities and operational innovations by leveraging AI, the European Pharmacy automation market is expected to surge in a substantial manner. Major drug developing companies in Europe are extensively deploying AI in their cycle of drug development.
Further, the growing aging population in Europe is another driving factor for the growth of the Europe pharmacy automation market in the future. With the increase in the elderly population, the healthcare segment in Europe is expected to transform to provide efficient healthcare to elderly patients along with flexible pharma deliveries.
Europe Pharmacy Automation Market Restraint:
Non-Favorable European Laws towards the Automation Industry
The European standards and laws for the automation industry and technologies like Artificial Intelligence (AI) are not in the best interest of the robotics and automation players who are willing to drive the market and develop solutions for industries like pharmacy automation. Also, the regulation considers some social scoring and biometric surveillance as unacceptable risks to aspects like privacy, non-discrimination, and other human rights.
Europe Pharmacy Automation Market Segmentation:
By Component
Hardware
Software
Services
By Technology
Robotics-Based Automation
Carousel-Based Systems
RFID and Barcode Integration
AI-Driven Workflow Systems
By Application
Automated Dispensing System
Automated Packaging and Labeling System
Automatic Storage and Retrieval System
IV Pharmacy
Others
By End-User
Hospital Pharmacy
Retail Pharmacy
By Country
United Kingdom
Germany
France
Spain
Others
Companies Profiled
Omnicell
McKesson Corporation
BD Rowa
Capsa Healthcare
ARxIUM
Swisslog Healthcare
Parata Systems
Table of Contents
82 Pages
- 1. EXECUTIVE SUMMARY
- 2. MARKET SNAPSHOT
- 2.1. Market Overview
- 2.2. Market Definition
- 2.3. Scope of the Study
- 2.4. Market Segmentation
- 3. BUSINESS LANDSCAPE
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Porter’s Five Forces Analysis
- 3.5. Industry Value Chain Analysis
- 3.6. Policies and Regulations
- 3.7. Strategic Recommendations
- 4. TECHNOLOGICAL OUTLOOK
- 5. EUROPE PHARMACY AUTOMATION MARKET BY COMPONENT
- 5.1. Introduction
- 5.2. Hardware
- 5.3. Software
- 5.4. Services
- 6. EUROPE PHARMACY AUTOMATION MARKET BY TECHNOLOGY
- 6.1. Introduction
- 6.2. Robotics-Based Automation
- 6.3. Carousel-Based Systems
- 6.4. RFID and Barcode Integration
- 6.5. AI-Driven Workflow Systems
- 7. EUROPE PHARMACY AUTOMATION MARKET BY APPLICATION
- 7.1. Introduction
- 7.2. Automated Dispensing System
- 7.3. Automated Packaging and Labeling System
- 7.4. Automatic Storage and Retrieval System
- 7.5. IV Pharmacy
- 7.6. Others
- 8. EUROPE PHARMACY AUTOMATION MARKET BY END-USER
- 8.1. Introduction
- 8.2. Hospital Pharmacy
- 8.3. Retail Pharmacy
- 9. COMPETITIVE ENVIRONMENT AND ANALYSIS
- 9.1. Major Players and Strategy Analysis
- 9.2. Market Share Analysis
- 9.3. Mergers, Acquisitions, Agreements, and Collaborations
- 9.4. Competitive Dashboard
- 10. COMPANY PROFILES
- 10.1. Omnicell
- 10.2. McKesson Corporation
- 10.3. BD Rowa
- 10.4. Capsa Healthcare
- 10.5. ARxIUM
- 10.6. Swisslog Healthcare
- 10.7. Parata Systems
- 11. APPENDIX
- 11.1. Currency
- 11.2. Assumptions
- 11.3. Base and Forecast Years Timeline
- 11.4. Key Benefits for the Stakeholders
- 11.5. Research Methodology
- 11.6. Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
